BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33278936)

  • 1. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
    Cairns M; Ceesay SJ; Sagara I; Zongo I; Kessely H; Gamougam K; Diallo A; Ogboi JS; Moroso D; Van Hulle S; Eloike T; Snell P; Scott S; Merle C; Bojang K; Ouedraogo JB; Dicko A; Ndiaye JL; Milligan P
    PLoS Med; 2021 Sep; 18(9):e1003727. PubMed ID: 34495978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
    Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P
    PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
    Beshir KB; Muwanguzi J; Nader J; Mansukhani R; Traore A; Gamougam K; Ceesay S; Bazie T; Kolie F; Lamine MM; Cairns M; Snell P; Scott S; Diallo A; Merle CS; NDiaye JL; Razafindralambo L; Moroso D; Ouedraogo JB; Zongo I; Kessely H; Doumagoum D; Bojang K; Ceesay S; Loua K; Maiga H; Dicko A; Sagara I; Laminou IM; Ogboi SJ; Eloike T; Milligan P; Sutherland CJ
    Lancet Infect Dis; 2023 Mar; 23(3):361-370. PubMed ID: 36328000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis.
    Gilmartin C; Nonvignon J; Cairns M; Milligan P; Bocoum F; Winskill P; Moroso D; Collins D
    Lancet Glob Health; 2021 Feb; 9(2):e199-e208. PubMed ID: 33482140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
    NDiaye JL; Cissé B; Ba EH; Gomis JF; Ndour CT; Molez JF; Fall FB; Sokhna C; Faye B; Kouevijdin E; Niane FK; Cairns M; Trape JF; Rogier C; Gaye O; Greenwood BM; Milligan PJ
    PLoS One; 2016; 11(10):e0162563. PubMed ID: 27764102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
    Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
    Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
    Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
    Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis.
    Pitt C; Ndiaye M; Conteh L; Sy O; Hadj Ba E; Cissé B; Gomis JF; Gaye O; Ndiaye JL; Milligan PJ
    Health Policy Plan; 2017 Nov; 32(9):1256-1266. PubMed ID: 28981665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali.
    Cairns ME; Sagara I; Zongo I; Kuepfer I; Thera I; Nikiema F; Diarra M; Yerbanga SR; Barry A; Tapily A; Coumare S; Milligan P; Tinto H; Ouédraogo JB; Chandramohan D; Greenwood B; Djimde A; Dicko A
    PLoS Med; 2020 Aug; 17(8):e1003214. PubMed ID: 32822362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
    Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
    Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.
    Lo AC; Faye B; Ba el-H; Cisse B; Tine R; Abiola A; Ndiaye M; Ndiaye JL; Ndiaye D; Sokhna C; Gomis JF; Dieng Y; Faye O; Ndir O; Milligan P; Cairns M; Hallett R; Sutherland C; Gaye O
    Malar J; 2013 Apr; 12():137. PubMed ID: 23617576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study.
    Roh ME; Zongo I; Haro A; Huang L; Somé AF; Yerbanga RS; Conrad MD; Wallender E; Legac J; Aweeka F; Ouédraogo JB; Rosenthal PJ
    J Infect Dis; 2023 Oct; 228(7):926-935. PubMed ID: 37221018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of adverse drug reactions during seasonal malaria chemoprevention campaigns in children aged 3–59 months in Burkina Faso].
    Ouoba J; Lankoandé-Haro S; Fofana S; Nacoulma AP; Kaboré L; Sombié I; Rouamba T; Kirakoya-Samadoulougou F
    Sante Publique; 2024 Jan; 35(5):121-132. PubMed ID: 38172043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
    Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan.
    Molina-de la Fuente I; Sagrado Benito MJ; Lasry E; Ousley J; García L; González V; Pasquale HA; Julla A; Uwiragiye P; Abdi AM; Chol BT; Abubakr B; Benito A; Casademont C; Berzosa P; Nanclares C
    Malar J; 2023 Nov; 22(1):345. PubMed ID: 37950227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
    Yaro JB; Tiono AB; Ouedraogo A; Lambert B; Ouedraogo ZA; Diarra A; Traore A; Lankouande M; Soulama I; Sanou A; Worrall E; Agboraw E; Sagnon N; Ranson H; Churcher TS; Lindsay SW; Wilson AL
    Sci Rep; 2022 Jan; 12(1):1402. PubMed ID: 35082312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention.
    Thwing J; Williamson J; Cavros I; Gutman JR
    Am J Trop Med Hyg; 2024 Jan; 110(1):20-31. PubMed ID: 38081050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.